| ¿µ¹® | peritoneal dialysis | ÇÑ±Û | º¹¸·Åõ¼® |
|---|---|---|---|
| ¼³¸í | Åõ¼®À̶õ, Ç÷¾×³»¿¡ Á¸ÀçÇÏ´Â ³ëÆó¹°À» ÄáÆÏ¿ÜÀÇ ´Ù¸¥ ¹æ¹ýÀ¸·Î Á¦°ÅÇÏ´Â °ÍÀ» ¸»ÇÑ´Ù. Á¤»óÀûÀ¸·Î ½ÅÀåÀº ¸ö¼Ó¿¡ ½ÎÀÎ ³ëÆó¹°À» ¼Òº¯À¸·Î ¹è¼³ÇÏ´Â ¿ªÇÒÀ» ÇÏÁö¸¸, ¸¸¼ºÄáÆÏ±â´É»ó½Ç ¶§ ³ëÆó¹°Àº ¸ö ¹ÛÀ¸·Î ³ª°¥ ¼ö ¾ø°Ô µÇ°í ü³»¿¡ ½×¿©¼ ÀÌ»óÀ» °¡Á®¿Â´Ù. º¹¸·Åõ¼®¿¡´Â °£°£È÷ Ç÷¾×Åõ¼®°ú °°ÀÌ ½ÃÇàÇÏ´Â °£ÇæÀûº¹¸·Åõ¼®ÀÌ ÀÖ°í, Ç×»ó ȯÀÚ°¡ Âø¿ëÇÏ´Â Continuous Ambulatory Peritoneal Dialysis(CAPD)°¡ ÀÖ´Ù.(±×¸² P-8) |
||
| ¿µ¹® | Dilatation and Curettage(D & C) | ÇÑ±Û | Àڱñܾ¼ú, ÀڱøñÈ®Àå |
|---|---|---|---|
| ¼³¸í | ÀÚ±ÃÀ̶õ žư¡ ¼öÅÂµÇ¾î¼ ºÐ¸¸Àü±îÁö ¹ßÀ°ÇÏ°í ¼ºÀåÇÏ´Â °ø°£ÀÌ´Ù. Àڱüӿ¡ º´º¯ÀÌ ÀÖ¾î ÀÓ½ÅÀÌ °è¼ÓµÉ ¼ö ¾ø°Å³ª ¾Æ´Ï¸é ´Ù¸¥ ÀÌÀ¯·Î ÀӽŵǾî Àִ žƸ¦ Á¦°ÅÇϰíÀÚ ÇÒ °æ¿ì¿¡ »ç¿ëµÇ´Â ¹æ¹ýÀÌ´Ù. ¿©±â¼ ±Ü¾î³»±â À§ÇÏ¿©´Â ¿ì¼± ÀÚ±ÃÀÇ ÀÔ±¸¿¡ ÇØ´çÇÏ´Â ÀڱøñÀ» È®Àå½ÃÄÑ¾ß ÇÑ´Ù. ¿©±â¿¡´Â ±Þ¼ÓÈ÷ È®ÀåÀ» ½ÃµµÇÏ´Â ¹ý°ú ¼¼È÷ È®ÀåÀ» ½ÃµµÇÏ´Â 2°¡Áö ¹æ¹ýÀÌ ÀÖ´Ù. ÀڱøñÀ» ±Þ¼ÓÈ÷ È®ÀåÇÒ ¶§´Â Çì°¡¸£ ¸ñ°üÈ®Àå±â(Hegar's dilatator)¸¦ »ç¿ëÇÑ´Ù. À̰ÍÀº ÀÛÀº ±Ý¼Ó¸·´ë·Î ÀÛÀº Å©±âºÎÅÍ Å« Å©±â±îÁö ´Ù¾çÇÑ Å©±â°¡ ÀÖ¾î¼ ¿ì¼± ÀÛÀº ¸·´ë·Î ½ÃÀÛÇÏ¿© Á¡Á¡ Å« Å©±âÀÇ ¸·´ë¸¦ Àڱøñ¿¡ ³Ö¾î¼ ÀڱøñÀ» È®Àå½ÃŲ´Ù. ¼¼È÷ È®Àå½Ãų ¶§´Â Laminaria tent¸¦ ¸ñ°ü¿¡ »ðÀÔÇÏ´Â ¹æ¹ýÀ» »ç¿ëÇÑ´Ù. Laminaria tent¶õ ÇØÃÊ·Î ¸¸µç ÀÛÀº ¸·´ë·Î ¼öºÐÀ» Èí¼öÇϸé Á¡Á¡ ´Ã¾î³ª´Â ¼ºÁúÀÌ ÀÖ´Ù. À̰ÍÀ» ÀÚ±ÃÀÇ ¸ñ¿¡ ³ÖÀ¸¸é À̰ÍÀÌ ¼öºÐÀ» Èí¼öÇÏ¿© ´Ã¾î³ª¹Ç·Î õõÈ÷ ÀÚ±ÃÀÇ ¸ñÀÌ ´Ã¾î³´Ù. ÀڱøñÀÌ ÃæºÐÈ÷ ´Ã¾î³ª¸é ±× ¼ÓÀ¸·Î ³¡ÀÌ ¼ù°¡¶ôó·³ »ý±ä ±â±¸¸¦ ³Ö¾î¼ ÀڱüÓÀÇ º´º¯À̳ª ÀÓ½ÅµÈ Å¾Ƹ¦ ±Ü¾î³»´Âµ¥ ¿©±â¿¡ »ç¿ëµÇ´Â ¼ù°¡¶ôó·³ »ý±ä ±â±¸¸¦ Å¥·¿À̶ó°í ÇÑ´Ù. Ãʱâ ÀÓ½ÅÁßÀý Áï À¯»ê°ú °°Àº ÀӽŰú °ü·ÃµÈ °æ¿ì»Ó¸¸ ¾Æ´Ï¶ó, ºñÀӽŠÀÚ±ÃÀÇ Àڱ󻸷Á¶Á÷ÀÇ Ã¤Ãë ¹× Á¦°Å¸¦ À§Çؼµµ ÇàÇØÁö´Â ¼ö±âÀÌ´Ù. ÀÌ´Â ¿øÄ¢ÀûÀ¸·Î ¸¶ÃëÇÏ¿¡ ½Ç½ÃµÇ´Â °ÍÀ¸·Î Àڱøñ°üÀ» È®ÀåÇÏ°í ±â±¸·Î Àڱà ³»¿ë¹°À» Á¦°ÅÇϰí Å¥·¿À¸·Î Àڱ󻺮À» ±ú²ýÀÌ ÇÑ´Ù. ÀÚ±Ãõ°øÀ̳ª ÀڱøñÀÇ ÆÄ¿ µîÀÇ À§ÇèÀÌ µû¸£¸ç, ¼ö¼úÈÄ °¨¿° ¶Ç´Â ÃâÇ÷ µî¿¡ ´ëÇÑ ÁÖÀǰ¡ ÇÊ¿äÇÏ´Ù. |
||
| OMI | Oocyte Maturation Inhibitor |
|---|---|
| MTP | maximum tolerated pressure; medial tibial plateau; median time to progression; metacarpophalangeal; ... |
| ABC | absolute basophil count; absolute bone conduction; acalculous biliary colic; acid balance control; a... |
| ASAB | Anti-Sperm Anti-Bodies |
| SCMCT | Sperm Cervical Mucus Contact Test |
| COC | Cumulus oocyte complex |
|---|---|
| OMI | Oocyte Maturation Inhibitor |
| OCC | oocyte cumulus complex |
| OPU | oocyte pick-up |
| IVF-ET | In vitro fertilization and embryo transfer |
| primary oocyte | <cell biology, gynaecology> The enlarging ovum before maturity is reached, as opposed to the secondary oocyte or polar body. (18 Nov 1997) |
|---|---|
| secondary oocyte | <gynaecology> An oocyte which arises from the primary oocyte (which was diploid) after it completes the first meiotic division after the body has become sexually mature. The secondary oocyte eventually divides into the mature egg or ovum (which is haploid) and a polar body (which degenerates), thus ending the second meiotic division. (13 Nov 1997) |
| oocyte | The developing female gamete before completion and release. The female germ cells in stages between the prophase of the first maturation division and the completion of the second maturation division. (21 Jun 2000) |
| oocyte donation | <gynaecology> Transfer of egg cell from donor to host mother. Oocytes are captured by laparoscopy, fertilised in vitro, and transferred to the recipient. Used for women with premature ovarian failure or severe genetic disorders, women who respond poorly to human menopausal gonadotropin, and women older than 40 years who do not conceive with use of other therapies. (21 Jun 2000) |
| oocyte expression | <molecular biology> Technique whereby the cellular machinery of an oocyte (typically that of Xenopus) is utilised to transcribe functional protein from microinjected RNA. (18 Nov 1997) |
| macrophages, peritoneal | Mononuclear phagocytes derived from bone marrow precursors but resident in the peritoneum. (12 Dec 1998) |
| panniculitis, peritoneal | Condition of the peritoneum, most commonly of the mesentery, but also of the omentum, characterised by tissue thickening, alteration of fat cells, infiltration of lipid-laden macrophages, and fibrosis. (12 Dec 1998) |
| greater peritoneal cavity | The space enclosed by the peritoneum. It is divided into two portions, the greater sac and the lesser sac or omental bursa, which lies behind the stomach. The two sacs are connected by the foramen of winslow, or epiploic foramen. (12 Dec 1998) |
| peritoneal | <anatomy> Of or pertaining to the peritoneum. Origin: Cf. F. Peritoneal. Source: Websters Dictionary (01 Mar 1998) |
| peritoneal button | A device used to drain ascitic fluid to subcutaneous space. (05 Mar 2000) |
| peritoneal cavity | The space enclosed by the peritoneum. It is divided into two portions, the greater sac and the lesser sac or omental bursa, which lies behind the stomach. The two sacs are connected by the foramen of winslow, or epiploic foramen. (12 Dec 1998) |
| peritoneal dialysis | <nephrology, procedure> In this type of dialysis, a special solution is run through a tube into the peritoneum, a thin tissue that lines the cavity of the abdomen. The bodys waste products are removed through the tube. There are three types of peritoneal dialysis. Continuous ambulatory peritoneal dialysis (CAPD), the most common type, needs no machine and can be done at home. Continuous cyclic peritoneal dialysis (CCPD) uses a machine and is usually performed at night when the person is sleeping. Intermittent peritoneal dialysis (IPD) uses the same type of machine as CCPD, but is usually done in the hospital because treatment takes longer. Haemodialysis and peritoneal dialysis may be used to treat people with diabetes who have kidney failure. (09 Oct 1997) |
| peritoneal dialysis, continuous ambulatory | Portable peritoneal dialysis using the continuous (24 hours a day, 7 days a week) presence of peritoneal dialysis solution in the peritoneal cavity except for periods of drainage and instillation of fresh solution. (12 Dec 1998) |
| peritoneal diseases | Conditions or disorders affecting the peritoneum. (12 Dec 1998) |
| peritoneal exudate | A term most commonly used to describe the fluid drained from the peritoneal cavity some time after the injection of an irritant solution. For example: a standard method for obtaining neutrophil leucocytes is to inject intraperitoneally saline with glycogen (to activate complement) and drain off the leucocyte rich peritoneal exudate some hours later. (18 Nov 1997) |
Á¦Ç°¸í |
ÆÇ¸Å»ç |
º¸ÇèÄÚµå | ¼ººÐ/ÇÔ·® | ±¸ºÐ/º¸Çè±Þ¿© |
|---|
Á¦Ç°¸í |
ÆÇ¸Å»ç |
º¸ÇèÄÚµå | ¼ººÐ/ÇÔ·® | ±¸ºÐ/º¸Çè±Þ¿© |
|---|